Periodic Reporting for period 1 - BioMedBC (Molecular profiling of Bladder Cancer to support personalized medicine)

Clinical Problem/ Disease burdenBladder Cancer (BC) is the 4th most common cancer type in men and the 11th in women. It is characterized by the highest recurrence rate and is the costliest cancer type to manage. The majority of BC (~70%) are classified as Non Muscle Invasive...